Anavex Life Sciences releases data presentation via webcast; details not disclosed in filing

ANAVEX LIFE SCIENCES CORP.

CEO Christopher Missling and CMO Ed Hammond presented data via webcast on February 2, 2022.
Exhibit 99.1 referenced but not included in provided text; content unknown.
No financial or clinical results specified in the 8-K filing.
Investors should review the full presentation for material information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.